AGAP2 and Familial prostate cancer: Next, to elucidate the regulatory mechanism of lncRNA AGAP2-AS1 in the progression of prostate cancer, the cells were transfected with si-AGAP2-AS1 and miR-195-5p inhibitor either alone or in combination.